CervoMed Inc. ( CRVO) - Key Metrics
CRVO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0 | -$0.87 | -$0.71 | -$0.71 |
| 2025Q3 | $0.03 | -$0.84 | -$0.70 | -$0.70 |
| 2025Q2 | ? | -$0.70 | -$0.73 | -$0.73 |
| 2025Q1 | ? | -$0.56 | -$0.45 | -$0.45 |
CRVO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -2.26 |
| 2025Q3 | ? | -2.42 |
| 2025Q2 | ? | -2.25 |
| 2025Q1 | ? | -4.07 |
CRVO
Price: $4.24
52 week price:
Earnings Per Share: -3.28 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 27.5 million